US awards up to $510 mln to boost domestic production of protective gear
Oct 3 (Reuters) -The Biden administration has granted up to $510 million to boost the domestic production of personal protective equipment (PPE) such as isolation gowns to restock the Strategic National Stockpile (SNS) in preparation for future public health emergencies, it said on Thursday.
WHY IT'S IMPORTANT
The U.S. SNS, the country's reserve of medical supplies for crisis situations, is intended to provide life-saving equipment in emergencies.
The investment is allocated to six companies that will produce isolation gowns manufactured in the U.S.
The contract recipients include Airboss Defense Group, Essential Safety Products, Gredale, New York Embroidery Studio, StringKing Lacrosse and Two One Two New York.
KEY QUOTE
"These awards also ensure that we are resupplying the SNS with domestically manufactured materials when possible. ASPR is committed to building a U.S. based supply chain that is prepared for future public health emergencies," said Dawn O'Connell, assistant secretary for preparedness and response.
CONTEXT
The SNS played a crucial role during the COVID pandemic by distributing PPE such as N95 respirators, masks, face shields, gloves and isolation gowns to healthcare facilities nationwide.
Reporting by Harshita Mary Varghese in Bengaluru; Editing by Alan Barona
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
